1. Home
  2. RGEN vs EVR Comparison

RGEN vs EVR Comparison

Compare RGEN & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$157.57

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Evercore Inc.

EVR

Evercore Inc.

HOLD

Current Price

$337.07

Market Cap

11.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
EVR
Founded
1981
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
11.7B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
RGEN
EVR
Price
$157.57
$337.07
Analyst Decision
Buy
Buy
Analyst Count
10
9
Target Price
$170.90
$326.56
AVG Volume (30 Days)
724.0K
345.8K
Earning Date
10-28-2025
10-29-2025
Dividend Yield
N/A
1.00%
EPS Growth
N/A
61.11
EPS
0.03
12.55
Revenue
$707,890,000.00
$3,542,875,000.00
Revenue This Year
$17.84
$25.39
Revenue Next Year
$12.57
$16.43
P/E Ratio
$5,097.58
$26.85
Revenue Growth
11.74
27.03
52 Week Low
$102.97
$148.63
52 Week High
$182.52
$364.42

Technical Indicators

Market Signals
Indicator
RGEN
EVR
Relative Strength Index (RSI) 47.50 61.16
Support Level $160.11 $319.69
Resistance Level $165.02 $349.91
Average True Range (ATR) 4.97 10.83
MACD -1.27 2.97
Stochastic Oscillator 7.12 72.03

Price Performance

Historical Comparison
RGEN
EVR

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About EVR Evercore Inc.

Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.

Share on Social Networks: